While some of my physical issues have improved over time and with treatment, others — like tinnitus, constant sinus pain and pressure, shortness of breath, joint pain, migraine headaches, and ...
SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.
Dr. Shira Doron, the point person for pandemic preparedness at Tufts Medical Center, reflects on how her team responded to the pandemic and how surprised she was about what happened outside the ...
The 13th Gut Microbiota for Health World Summit, taking place March 15-16 in Washington, D.C., will reveal how cutting-edge research on gut microbiome science is being applied to clinical practice.
It’s been five years since COVID-19 arrived in the U.S., and in that time, adults age 50 and older have accounted for roughly 94 percent of the 1.2-plus million American deaths.
That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...
A study led by the University of Texas Health Science Center at San Antonio found women had a 31% greater risk of developing ...
Developing myalgic encephalomyelitis/chronic fatigue syndrome is significantly more likely after a case of COVID-19, an ...
Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...
We invite you to watch an Eyewitness News special, COVID Impact: 5 Years Later, as we examine how the virus has changed our lives and continues to impact us.
The pandemic may be over, but the endemic disease is still a threat, especially for older adults and those with certain risk ...
MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be life-threatening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback